The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Open accessAbstract
The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on the previous literature42,43,46, we reasoned that cathepsin B leaking from the destabilized lysosomes may mediate the NLRP3 inflammasome activation upon SHIP1 inhibition11.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibrillar Aβ (fAβ), following phagocytosis by microglia, activates the NLRP3 inflammasome and leads to increases in secretion of IL-1β and IL-18.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained elevations of IL-1β have been postulated to play a key role in AD pathogenesis [6, 12–14].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Halle et al. found that fibrillar Aβ can induce the secretion of IL-1β which depends on the presence of NLRP3.352,353”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [352]
The cited source says what the claim attributes to it.
In the citing paper
“lysosomal cathepsins, such as cathepsin B, can induce NLRP3 inflammasome activation upon leaking into the cytosol following lysosomal membrane permeabilization (LMP)42,43”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“fAβ phagocytosis results in lysosomal dysfunction and release of lysosomal contents into the cytoplasm, including the lysosomal protease cathepsin B, which is a mediator of inflammasome activation induced by Aβ [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In line with these findings, another study showed that aggregated tau seeds activated the NLRP3 inflammasome in primary mouse microglia by inducing lysosomal destabilization and release of the lysosomal protease cathepsin B, similar to fAβ [78, 82].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In parallel, reduction of SHIP1 activity is poised to disinhibit signaling pathways that are involved in the phagocytosis of Aβ, which is a required step for Aβ-induced activation of the NLRP3 inflammasome [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
In the citing paper
“Notably, Aβ also can activate NF-κB signaling and the NLRP3-ASC inflammasome [426, 427], suggesting that Aβ and tau share common mechanisms in microglia activation.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [426]
In the citing paper
“Following phagocytosis by microglia, Aβ activates the NLRP3 inflammasome leading to caspase-1 activation and IL-1β maturation and release (Halle et al., 2008).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Halle et al., 2008
In the citing paper
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“In support of this, direct treatment of ATP on primed microglia is sufficient for maturation and release of IL-1β in vitro (Halle et al, 2008) and does so via the P2X 7 receptor (Colomar et al, 2003) expressed on microglia (Monif et al, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Halle et al, 2008
In the citing paper
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al, 2008; Venegas et al, 2017; Ising et al, 2019).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Halle et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Cited by
Sorted by citations
Items 901–1,000 of 1,015
Orlowski, G. M., Sharma, S., Colbert, J. D., Bogyo, M. S., Robertson, S. A., Kataoka, H., Chan, F. K.-M., & Rock, K. L. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0316-152r · Cited by 65
Lei, C., Lin, R., Wang, J., Tao, L., Fu, X., Qiu, Y., & Lei, B. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.053 · Cited by 66
Zheng, B., Zhang, S., Ying, Y.-L., Guo, X., Li, H., Xu, L., & Ruan, X. (2018) · Bioscience Reports · doi:10.1042/bsr20180892 · Cited by 65
Update of inflammasome activation in microglia/macrophage in aging and aging‐related disease
Hu, M., Lin, Y., Zhang, B., Lu, D., Lu, Z., & Cai, W. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13262 · Cited by 67
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
Choudhury, S. M., Ma, X., Abdullah, S. W., & Zheng, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s295706 · Cited by 66
The mTOR–lysosome axis at the centre of ageing
Carosi, J. M., Fourrier, C., Bensalem, J., & Sargeant, T. J. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13347 · Cited by 70
NLRP3 inflammasome in health and disease (Review)
Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., & Liu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5489 · Cited by 70
Interleukin-1α and HMGB1 Mediate Hippocampal Dysfunction in SIGIRR-Deficient Mice
Costello, D. A., Watson, M. B., Cowley, T. R., Murphy, N., Murphy‐Royal, C., Garlanda, C., & Lynch, M. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6676-10.2011 · Cited by 65
Membrane Localization of β-Amyloid 1–42 in Lysosomes
Liu, R., Zhou, Q., Ji, S., Zhou, Q., Feng, D., Wu, Y., & Sui, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036798 · Cited by 64
Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro‐inflammatory phenotype
Xiong, J., & Kielian, T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12385 · Cited by 64
Tanaka, T., Takahashi, K., Yamane, M., Tomida, S., Nakamura, S., Oshima, K., Niwa, A., Nishikomori, R., Kambe, N., Hara, H., et al. (2012) · Blood · doi:10.1182/blood-2012-03-417881 · Cited by 66
Woodling, N. S., & Andreasson, K. I. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00016 · Cited by 62
Inflammasomes: Key Mediators of Lung Immunity
Howrylak, J. A., & Nakahira, K. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105229 · Cited by 67
Liu, J., Jia, Z., & Gong, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680648 · Cited by 65
Budden, C. F., Gearing, L. J., Kaiser, R., Standke, L., Hertzog, P. J., & Latz, E. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12127 · Cited by 66
Self-citationFerroptosis, Pyroptosis, and Cuproptosis in Alzheimer’s Disease
Wang, Q., Sun, J., Chen, T., Song, S., Hou, Y., Feng, L., Fan, C., & Li, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00343 · Cited by 65
Targeting danger-associated molecular patterns after myocardial infarction
van Hout, G. P. J., Arslan, F., Pasterkamp, G., & Hoefer, I. E. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1088005 · Cited by 67
Oleszycka, E., Moran, H. B. T., Tynan, G. A., Hearnden, C. H. A., Coutts, G., Campbell, M., Allan, S. M., Scott, C. J., & Lavelle, E. C. (2015) · FEBS Journal · doi:10.1111/febs.13546 · Cited by 62
Inflammasomes in infection and inflammation
McIntire, C. R., Yeretssian, G., & Saleh, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0312-3 · Cited by 64
Interleukin‐1β orchestrates underlying inflammatory responses in microglia via Krüppel‐like factor 4
Kaushik, D. K., Thounaojam, M. C., Kumawat, K. L., Gupta, M., & Basu, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12382 · Cited by 63
Alvarado, R., To, J., Lund, M. E., Pinar, A. A., Mansell, A. S., Robinson, M. W., O’Brien, B. A., Dalton, J. P., & Donnelly, S. (2016) · The FASEB Journal · doi:10.1096/fj.201500093r · Cited by 61
Ji, X., Xu, B., Yao, M., Mao, Z., Zhang, Y., Xu, G., Tang, Q., Wang, X., & Xia, Y. (2016) · Toxicology · doi:10.1016/j.tox.2016.11.009 · Cited by 63
Son, S., Hwang, I., Han, S. H., Shin, J., Shin, O. S., & Yu, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806307 · Cited by 64
Love and death: microglia, NLRP3 and the Alzheimer's brain
Goldmann, T., Tay, T. L., & Prinz, M. (2013) · Cell Research · doi:10.1038/cr.2013.24 · Cited by 63
Zhang, C., Li, X., Hu, X., Xu, Q., Zhang, Y., Liu, H., Diao, Y., Zhang, X., Li, L., Yu, J., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107412 · Cited by 64
Wang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 62
Zhang, H., Peng, J., Cheng, X.-B., Shi, B., Zhang, M., & Xu, R. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1632-z · Cited by 62
The role of inflammation and interleukin-1 in acute cerebrovascular disease
Brough, D., & Galea, J. P. (2013) · Journal of Inflammation Research · doi:10.2147/jir.s35629 · Cited by 63
Loock, J., Lamprecht, P., Timmann, C., Mrowietz, U., Csernok, E., & Gross, W. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.066 · Cited by 62
FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
Yao, S., Li, L., Sun, X., Hua, J., Zhang, K., Hao, L., Liu, L., Shi, D., & Zhou, H. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09843-4 · Cited by 62
Betaine Inhibits Interleukin-1β Production and Release: Potential Mechanisms
Xia, Y., Chen, S., Zhu, G., Huang, R., Yin, Y., & Ren, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02670 · Cited by 61
Chiu, Y., Lin, C., Lee, M.-C., Hsieh‐Li, H. M., Chen, C., Wu, Y., Chang, K., & Lee‐Chen, G. (2021) · Aging · doi:10.18632/aging.203125 · Cited by 61
The Interplay between Autophagy and NLRP3 Inflammasome in Ischemia/Reperfusion Injury
Lv, S., Liu, H., & Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168773 · Cited by 60
Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease
Helmfors, L., Boman, A., Civitelli, L., Nath, S., Sandin, L., Janefjord, C., McCann, H., Zetterberg, H., Blennow, K., Halliday, G. M., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.024 · Cited by 62
Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation
Thuc, O. L., Cansell, C., Bourourou, M., Denis, R., Stobbe, K., Devaux, N., Guyon, A., Cazareth, J., Heurteaux, C., Rostène, W. H., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541499 · Cited by 60
GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics
Tang, T., Gong, T., Jiang, W., & Zhou, R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.002 · Cited by 64
NLRP3 inflammasomes that induce antitumor immunity
Zhivaki, D., & Kagan, J. C. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.05.001 · Cited by 61
Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome
Liu‐Bryan, R. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.93 · Cited by 62
Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice
Tzeng, T.-C., Hasegawa, Y., Iguchi, R., Cheung, A., Caffrey, D. R., Thatcher, E. J., Mao, W., Germain, G., Tamburro, N. D., Okabe, S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801802115 · Cited by 67
Self-citationChiarini, A., Gui, L., Viviani, C., Armato, U., & Prà, I. D. (2023) · Biomedicines · doi:10.3390/biomedicines11040999 · Cited by 62
Savic, S., Dickie, L. J., Wittmann, M., & McDermott, M. (2012) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.07.009 · Cited by 62
The neuroendocrine control of the innate immune system in health and brain diseases
Bellavance, M., & Rivest, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01129.x · Cited by 61
Impact of aging immune system on neurodegeneration and potential immunotherapies
Liang, Z., Zhao, Y., Ruan, L., Zhu, L., Jin, K., Zhuge, Q., Su, D., & Zhao, Y. L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.006 · Cited by 64
NLRP3 inflammasome in colitis and colitis-associated colorectal cancer
Perera, A. P., Sajnani, K., Dickinson, J. L., Eri, R. D., & Körner, H. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9783-2 · Cited by 61
Ma, Y., Bao, J., Zhao, X., Shen, H., Lv, J., Ma, S., Zhang, X., Li, Z., Wang, S., Wang, Q., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026864 · Cited by 60
Pyroptotic death storms and cytopenia
Croker, B. A., O’Donnell, J. A., & Gerlic, M. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.002 · Cited by 60
Lee, J., Kim, H., Kim, J., Yook, T. H., Kim, K. H., Lee, J. Y., & Yang, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031324 · Cited by 61
Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases
Brahadeeswaran, S., Sivagurunathan, N., & Latchoumycandane, C. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02683-5 · Cited by 63
Hulse, J. P., & Bhaskar, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805169 · Cited by 63
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups
Sæther, L. S., Ueland, T., Haatveit, B. C., Maglanoc, L. A., Szabó, A., Djurovic, S., Aukrust, P., Roelfs, D., Mohn, C., Ormerod, M. B. E. G., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01924-w · Cited by 61
Liu, Z., Deng, Q., Qin, G., Yang, J., Zhang, H., Ren, J., & Qu, X. (2023) · Chem · doi:10.1016/j.chempr.2023.06.003 · Cited by 59
TLR3‐mediated IFN‐β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor‐like
Siednienko, J., Halle, A., Nagpal, K., Golenbock, D. T., & Miggin, S. M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040547 · Cited by 59
Self-citationStavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy
Rosa, F. L., Saresella, M., Marventano, I., Piancone, F., Ripamonti, E., Al‐Daghri, N. M., Bazzini, C., Zoia, C., Conti, E., Ferrarese, C., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181259 · Cited by 61
Skeldon, A. M., & Saleh, M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00015 · Cited by 62
Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?
Meyer‐Luehmann, M., & Prinz, M. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.011 · Cited by 58
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Calvo-Rodríguez, M., Kharitonova, E. K., & Bacskai, B. J. (2020) · Cells · doi:10.3390/cells9112513 · Cited by 60
Fernando, K., & Wijayasinghe, Y. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.746631 · Cited by 57
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
Lu, R., Zhang, L., & Yang, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1018848 · Cited by 58
Bahri, F., Mansoori, M., Vafaei, S., Fooladi, S., Mir, Y., Mehrabani, M., Hozhabri, Y., Nematollahi, M. H., & Iravani, S. (2024) · Materials Advances · doi:10.1039/d3ma00856h · Cited by 63
Zheng, Y., Zhang, X., Wang, Z., Zhang, R., Wei, H., Xu, Y., Jiang, X., & Yang, L. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400459 · Cited by 61
The role of innate immune signals in immunity to Brucella abortus
Gomes, M. T. R., Campos, P. C., de Almeida, L. A., Oliveira, F. S., Costa, M. M. S., Marim, F. M., Pereira, G. D. S., & Oliveira, S. C. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00130 · Cited by 58
Nlrp6 promotes recovery after peripheral nerve injury independently of inflammasomes
Ydens, E., Demon, D., Lornet, G., Winter, V. D., Timmerman, V., Lamkanfi, M., & Janssens, S. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0367-8 · Cited by 60
Samelko, L., Landgraeber, S., McAllister, K., Jacobs, J. J., & Hallab, N. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160141 · Cited by 60
Protective Effect of Genistein against Neuronal Degeneration in ApoE−/− Mice Fed a High-Fat Diet
Park, Y., Ko, J., Jeon, S., & Kwon, Y. (2016) · Nutrients · doi:10.3390/nu8110692 · Cited by 58
Martinez, E. M., Young, A. L., Patankar, Y. R., Berwin, B. L., Wang, L., von Herrmann, K. M., Weier, J. M., & Havrda, M. C. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx117 · Cited by 59
Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
Yu, Q., Zhao, T., Liu, M., Cao, D., Li, J., Li, Y., Xia, M., Wang, X., Zheng, T., Liu, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707696 · Cited by 61
Vaccari, J. P. D. R., Patel, H. H., Brand, F. J., Pérez‐Pinzón, M. A., Bramlett, H. M., & Raval, A. P. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13404 · Cited by 58
Domizio, J. D., Dorta-Estremera, S. M., Gagea, M., Ganguly, D., Meller, S., Li, P., Zhao, B., Tan, F. K., Bi, L., Gilliet, M. F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206923109 · Cited by 54
Interleukin-17A Induces IL-1β Secretion From RPE Cells Via the NLRP3 Inflammasome
Zhang, S., Yu, N., Zhang, R., Zhang, S., & Wu, J. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17578 · Cited by 56
Mendiola, A. S., Garza, R., Cardona, S. M., Mythen, S. A., Lira, S. A., Akassoglou, K., & Cardona, A. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00303 · Cited by 57
Hung, W., Ho, C., & Pan, M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900550 · Cited by 57
Atluri, V. S. R., Tiwari, S., Rodriguez, M., Kaushik, A. K., Yndart, A., Kolishetti, N., Yatham, M., & Nair, M. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00342 · Cited by 62
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111428 · Cited by 59
Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases
Rashidi, M., Wicks, I. P., & Vince, J. E. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.06.005 · Cited by 58
Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome
Bagherniya, M., Khedmatgozar, H., Fakheran, O., Xu, S., Johnston, T. P., & Sahebkar, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7118 · Cited by 60
Extralysosomal cathepsin B in central nervous system: Mechanisms and therapeutic implications
Ni, J., Lan, F., Xu, Y. C., Nakanishi, H., & Li, X. (2022) · Brain Pathology · doi:10.1111/bpa.13071 · Cited by 56
Cheon, S. Y., & Song, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00836-0 · Cited by 58
Zhang, D., Zhang, Y., Pan, J., Cao, J., Sun, X., Li, X., Zhang, L., & Qin, C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14219 · Cited by 59
The Interplay between NLRs and Autophagy in Immunity and Inflammation
Carneiro, L. A. M., & Travassos, L. H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00361 · Cited by 58
Hao, W., Liu, Y., Liu, S., Walter, S., Grimm, M. O. W., Kiliaan, A. J., Penke, B., Hartmann, T., Rübe, C. E., Menger, M. D., et al. (2010) · Brain · doi:10.1093/brain/awq325 · Cited by 54
The lysosomal storage disease continuum with ageing-related neurodegenerative disease
Lloyd‐Evans, E., & Haslett, L. J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.07.005 · Cited by 59
The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
Karasawa, T., & Takahashi, M. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0050-9 · Cited by 59
Krajnak, K., & Dahl, R. S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.03.052 · Cited by 56
Tsatsanis, A., McCorkindale, A. N., Wong, B. X. W., Patrick, E., Ryan, T. M., Evans, R. W., Bush, A. I., Sutherland, G. T., Sivaprasadarao, A., Guennewig, B., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01248-1 · Cited by 57
Regulation of Caspases in the Nervous System
Troy, C. M., Akpan, N., & Jean, Y. Y. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385504-6.00007-5 · Cited by 58
Yang, Y., Li, S., Huang, H. M., Lv, J., Chen, S., Dias, A. C. P., Li, Y., Liu, X., & Wang, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00834 · Cited by 55
Potential neurotoxic activity of diverse molecules released by microglia
Lindhout, I. A., Murray, T. E., Richards, C. M., & Klegeris, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105117 · Cited by 58
Uric Acid and Xanthine Oxidoreductase in Wound Healing
Fernandez, M. L., Upton, Z., & Shooter, G. K. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0396-1 · Cited by 55
Mankan, A. K., Kubarenko, A. V., & Hornung, V. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04534.x · Cited by 58
Self-citationSarvestani, S. T., & McAuley, J. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.10.020 · Cited by 55
Silva, A. R., Grosso, C., Delerue-Matos, C. M., & Rocha, J. M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.028 · Cited by 56
Park, M. H., Lee, M., Nam, G., Kim, M., Kang, J., Choi, B. J., Jeong, M. S., Park, K. H., Han, W. H., Tak, E., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916318116 · Cited by 54
Enduring Changes in Neuronal Function upon Systemic Inflammation Are NLRP3 Inflammasome Dependent
Beyer, M. M. S., Lonnemann, N., Remus, A., Latz, E., Heneka, M. T., & Korte, M. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0200-20.2020 · Cited by 55
Self-citationVontell, R. T., de Rivero Vaccari, J. P., Sun, X., Gultekin, S. H., Bramlett, H. M., Dietrich, W. D., & Keane, R. W. (2023) · Brain Pathology · doi:10.1111/bpa.13142 · Cited by 57
Role of pattern recognition receptors of the neurovascular unit in inflamm-aging
Wilhelm, I., Nyúl-Tóth, Á., Kozma, M., Farkas, A. E., & Krizbai, I. A. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00106.2017 · Cited by 56
Li, Y., Xu, P., Shan, J., Sun, W., Ji, X., Chi, T., Liu, P., & Zou, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109618 · Cited by 52
An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
Raneros, A. B., Bernet, C. R., Flórez, A. B., & Suárez-Álvarez, B. (2021) · Biomedicines · doi:10.3390/biomedicines9111614 · Cited by 53
Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus
Zhang, R., Xie, Q., Lu, X., Fan, R., & Tong, N. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01325-9 · Cited by 63
γ-Secretase and its modulators: Twenty years and beyond
Xia, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.011 · Cited by 54
Metadata
- Authors
- Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- University of Freiburg (DE)
- Corresponding author
- Golenbock, Douglas T
- ORCID
- Venue
- Nature Immunology
- Published
- 2008-07-11
- Volume
- 9
- Issue
- 8
- Pages
- 857-865
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3101478
- OpenAlex
- W2119098586
- Cited by
- 2,441
- References
- 50
- Citations by year
- 2026: 92 · 2025: 124 · 2024: 143 · 2023: 165 · 2022: 191 · 2021: 188 · 2020: 169 · 2019: 151 · 2018: 136 · 2017: 139 · 2016: 138 · 2015: 146 · 2014: 149 · 2013: 153 · 2012: 98
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute on Aging (R01AG020255, AG20255)
- National Institute of General Medical Sciences (R37GM054060, R01GM054060, GM 54060)
- National Institute of Allergy and Infectious Diseases (AI065483, R01AI065483)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NLRP3 inflammasome, amyloid-beta, Alzheimer's disease, innate immunity, IL-1β, caspase-1, microglia, phagocytosis, lysosomal damage, cathepsin B, neuroinflammation, neurotoxicity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Carrier Proteins, Immunity, Innate, Inflammation, Amyloid beta-Peptides, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
